Improving nonattendance rates among pediatric patients with Medicaid or private insurance

Chaudhry, Sofia; Siegfried, Elaine C.; Sheikh, Umar A.; Simonetta, Cassandra; Butala, Niraj; Armbrecht, Eric S.

doi:10.1016/j.jaad.2019.02.018

Cited by 17 publications

(20 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The overall nonattendance rate across all clinics was 10.5%. Similar to the findings of Chaudhry et al, 1 patients receiving Medicaid benefits (20.6%) had a higher average nonattendance rate than those with private insurance (9.8%) (P \ .0001). Nonattendance rates varied by lead time for all patients and for Medicaid-insured and privately insured patient subgroups.…”

supporting

confidence: 84%

Re-evaluating the relationship between appointment nonattendance and appointment lead time

Gunasekera

Pahalyants

Salian

et al. 2020

Journal of the American Academy of Dermatology

View full text Add to dashboard Cite

supporting

confidence: 84%

Re-evaluating the relationship between appointment nonattendance and appointment lead time

Gunasekera

Pahalyants

Salian

et al. 2020

Journal of the American Academy of Dermatology

View full text Add to dashboard Cite

“…We had found a significant decrease in nonattendance rates for all insurance types when appointments could be scheduled either 2 or 4 weeks in advance compared with an open scheduling policy with longer wait times. 2 The adult data reported by Gunasekera et al 1 reflected our own findings. They found that nonattendance rates were lowest when appointment lead times were less than 29 days, for all insurance types, except for appointments scheduled longer than 6 months in advance ($180 days).…”

supporting

confidence: 81%

Reply to: “Re-evaluating the relationship between appointment nonattendance and appointment lead time”

Chaudhry

Siegfried

Armbrecht

2020

Journal of the American Academy of Dermatology

Self Cite

View full text Add to dashboard Cite

“…Several studies have shown that patients enrolled in Medicaid are less likely to gain outpatient access to specialty providers [4][5][6][7]. A number of factors, including unfavorable fee-for-service reimbursement, longer wait times for payments, and higher clinic nonattendance rates, contribute to the dearth of specialists accepting Medicaid patients [5,8].…”

Section: Introductionmentioning

confidence: 99%

Effects of variations in access to care for children with atopic dermatitis

et al. 2020

View full text Add to dashboard Cite

Background An estimated 50% of children in the US are Medicaid-insured. Some of these patients have poor health literacy and limited access to medications and specialty care. These factors affect treatment utilization for pediatric patients with atopic dermatitis (AD), the most common inflammatory skin disease in children. This study assesses and compares treatment patterns and healthcare resource utilization (HCRU) between large cohorts of Medicaid and commercially insured children with AD. Methods Pediatric patients with AD were identified from 2 large US healthcare claims databases (2011–2016). Included patients had continuous health plan eligibility for ≥6 months before and ≥12 months after the first AD diagnosis (index date). Patients with an autoimmune disease diagnosis within 6 months of the index date were excluded. Treatment patterns and all-cause and AD-related HCRU during the observation period were compared between commercially and Medicaid-insured children. Results A minority of children were evaluated by a dermatology or allergy/immunology specialist. Several significant differences were observed between commercially and Medicaid-insured children with AD. Disparities detected for Medicaid-insured children included: comparatively fewer received specialist care, emergency department and urgent care center utilization was higher, a greater proportion had asthma and non-atopic morbidities, high- potency topical corticosteroids and calcineurin inhibitors were less often prescribed, and prescriptions for antihistamines were more than three times higher, despite similar rates of comorbid asthma and allergies among antihistamine users. Treatment patterns also varied substantially across physician specialties. Conclusions Results suggest barriers in accessing specialty care for all children with AD and significant differences in management between commercially and Medicaid-insured children. These disparities in treatment and access to specialty care may contribute to poor AD control, especially in Medicaid-insured patients.

show abstract

Improving nonattendance rates among pediatric patients with Medicaid or private insurance

Cited by 17 publications

References 11 publications

Re-evaluating the relationship between appointment nonattendance and appointment lead time

Re-evaluating the relationship between appointment nonattendance and appointment lead time

Reply to: “Re-evaluating the relationship between appointment nonattendance and appointment lead time”

Effects of variations in access to care for children with atopic dermatitis

Contact Info

Product

Resources

About